Abstract
This review, based on the BSMB Fell‐Muir Lecture I presented in July 2018 at the Matrix Biology Europe Conference in Manchester, gives a personal perspective of my own laboratory's contributions to research into type X collagen, metaphyseal chondrodysplasia type Schmid and potential treatments for this disorder that are currently entering clinical trial. I have tried to set the advances made in the context of the scientific technologies available at the time and how these have changed over the more than three decades of this research.
Original language | English |
---|---|
Pages (from-to) | 4-11 |
Number of pages | 8 |
Journal | International Journal of Experimental Pathology |
Volume | 100 |
Issue number | 1 |
Early online date | 26 Mar 2019 |
DOIs | |
Publication status | Published - 16 Apr 2019 |